Massachusetts Life Sciences Center

Massachusetts Life Sciences Center

Government Administration

Waltham, Massachusetts 11,073 followers

The Heart of the Hub

About us

The Massachusetts Life Sciences Center (MLSC) is an economic development and investment agency dedicated to supporting the growth and development of the life sciences in Massachusetts, home to the most verdant and productive life sciences ecosystem in the world. Through public-private funding initiatives, the MLSC supports innovation, research & development, commercialization, and manufacturing activities in the fields of biopharma, medical device, diagnostics, and digital health. Since its creation in 2007, the MLSC has strategically deployed over $700 million in Massachusetts, through a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs. These investments have created thousands of jobs and propelled the development of new therapies, devices, and scientific advancements that are improving patient health and well-being in Massachusetts and beyond.

Website
http://www.masslifesciences.com
Industry
Government Administration
Company size
11-50 employees
Headquarters
Waltham, Massachusetts
Type
Government Agency
Founded
2007
Specialties
life sciences, grants, biotech, economic development, medical device, tax incentives, investment, workforce pipeline, biomanufacturing, internships, capital investment, innovation economy, and big data

Locations

Employees at Massachusetts Life Sciences Center

Updates

  • The MLSC is excited to launch the 16th round of the Tax Incentive program. The program provides incentives to companies engaged in life sciences research and development, commercialization and manufacturing in Massachusetts looking to expand their efforts by creating new, long-term jobs in the state. The Center is excited to continue this program to attract and retain life sciences companies of all sizes. Of note, new and returning modifications of the program include: ☑️ Average rate per job begins at $16,000 ☑️ Premium award per net new job to companies creating biomanufacturing positions ☑️ Reduced new job retention compliance period from 5 years to 3 years ☑️ Increased flexibility to support smaller companies and those located in emerging regional clusters by reducing minimum net new job creation from 10 to 5 positions Learn more: https://ow.ly/laSL50UsHVV

    • No alternative text description for this image
  • We are excited to announce new rounds of programming to support our life sciences workforce. To cultivate a diverse and robust life sciences workforce, we must help inspire, train, and create opportunities for the next generation of life sciences professionals. Learn more about the latest program rounds: Workforce Development Capital Grants: Funding of up to $750,000 per project for equipment, renovation, lab furniture, materials, supplies, and/or technology that will prepare students for high-demand career opportunities in the life sciences. Learn more: https://lnkd.in/dm2u9Mr6 STEM Equipment and Professional Development Grants: Funding to public schools (grades 3-12) and curriculum providers for the purpose of teacher professional development and the purchase of equipment, materials, supplies, and technology needed to support new or expanded curriculum. Learn more: https://lnkd.in/ezeScC2

    • No alternative text description for this image
  • A day to celebrate what's next for our ecosystem and our Commonwealth. Today, we gathered at the Ragon Institute of Mass General Brigham, MIT, and Harvard in celebration of the passage of the #MassLeadsAct which reauthorizes the state’s Life Sciences Initiative over 10 years, providing critical capital funds and expanding the tax credit program to spur job creation and growth. The time is now to work collaboratively and own the #1 global life sciences position, defining the standard for medical research, industry partnerships, and equitable healthcare delivery. 

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +3
  • It was a privilege to have the MLSC Team and Team Massachusetts represent the Commonwealth at this year's MEDICA - Leading International Trade Fair, one of the largest global convenings for medical technology & healthcare. The Massachusetts ecosystem is the ideal location to grow your thriving business. Explore what resources the Commonwealth can offer to help you at any stage and how to take the next steps. Get in touch today. Learn more about Why Massachusetts: https://lnkd.in/eiKvNkcq

    • No alternative text description for this image
  • #DidYouKnow Breast cancer is the second most common cancer among women in the United States. Moreover, it the second leading cause of cancer death among women in the country. Dr. Elizabeth Mittendorf, Director of the Breast Immuno-Oncology program, Co-Leader of the Parker Institute for Cancer Immunotherapy at the Dana-Farber Cancer Institute, and Co-Leader of the Breast Program for the Dana-Farber/Harvard Cancer Center, is leveraging digital pathology to identify and cure high risk breast cancer. Partnering with PathAI, Dr. Mittendorf was awarded more than $740,000 through the MLSC’s Women’s Health Collaboration program in 2021. Her project involved designing computer algorithms capable of identifying features in tumor biopsies and surgical specimens that can distinguish between high- and low-risk breast tumors. The Collaboration program and other efforts part of the MLSC Women’s Health Initiative are accepting applications through Dec. 6, 2024 at 1 p.m. EST. Read more: https://lnkd.in/gVuc5ZMg

    • No alternative text description for this image
  • A momentous day for our ecosystem and our Commonwealth and a new chapter for the Massachusetts Life Sciences Initiative. Today, Governor Maura Healey signed into law the Mass Leads Act, an economic development bill that will build on the success of our renowned life sciences sector. The package will create jobs, support business growth, expand workforce development programs and support rural and regional economic development initiatives. Governor Healey will host a ceremonial signing event in the near future. The legislation positions the Healey-Driscoll Administration to begin executing on the billion-dollar initiatives. This includes a $500 million capital reauthorization of the state’s Life Sciences Initiative over 10 years and an expansion of a tax credit program designed to spur job creation and growth in the life sciences industry. Read more: https://lnkd.in/ePEk_rse

    • No alternative text description for this image
  • On behalf of the MLSC, we share in extending our condolences to the family, friends, and loved ones of former Executive Office of Housing and Economic Development Secretary Greg Bialecki. As Secretary and Co-Chair of the MLSC's Board of Directors, he provided a powerful and engaged voice, support, and leadership for the Center and our broader life sciences ecosystem in Massachusetts.

    Last week, we lost an important member of our economic development family with the passing of former Executive Office of Housing and Economic Development Secretary Greg Bialecki. Greg was a super talented individual with a passion for housing, permitting, and economic development and had an incredible impact while serving our state as secretary from 2009 to 2015. He was also a generous and thoughtful friend to so many in our office. We extend our condolences to his family and will continue to honor his legacy in our work on behalf of the communities and people of Massachusetts.

    • No alternative text description for this image

Similar pages

Browse jobs

Funding

Massachusetts Life Sciences Center 2 total rounds

Last Round

Grant

US$ 2.8M

See more info on crunchbase